Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
13.86
-0.18 (-1.28%)
At close: Jul 10, 2026, 4:00 PM EDT
13.72
-0.14 (-1.01%)
After-hours: Jul 10, 2026, 4:10 PM EDT
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $970.52 million as of July 10, 2026. Its market cap has increased by 34.33% in one year.
Market Cap
970.52M
Enterprise Value
917.01M
1-Year Change
34.33%
Ranking
Category
Stock Price
$13.86
Market Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from $128.85M to $970.52M, an increase of 653.19%. That is a compound annual growth rate of 7.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 970.52M | -15.40% |
| Dec 31, 2025 | 1.15B | 76.58% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avalo Therapeutics | 1.05B |
| Janux Therapeutics | 1.02B |
| Arbutus Biopharma | 1.02B |
| Inventiva | 1.01B |
| Geron | 1.00B |
| Lexicon Pharmaceuticals | 999.44M |
| Annexon | 973.22M |
| Alto Neuroscience | 970.00M |